Identification of a Novel Integrin αvβ3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
CCN1 (CYR61) is a matricellular inducer of angiogenesis essential for successful vascular development. Though devoid of the canonical RGD sequence motif recognized by some integrins, CCN1 binds to, and functions through integrin alphavbeta3 to promote pro-angiogenic activities in activated endothelial cells. In this study we identify a 20-residue sequence, V2 (NCKHQCTCIDGAVGCIPLCP), in domain II of CCN1 as a novel binding site for integrin alphavbeta3. Immobilized synthetic V2 peptide supports alphavbeta3-mediated cell adhesion; soluble V2 peptide inhibits endothelial cell adhesion to CCN1 and the homologous family members CCN2 (connective tissue growth factor, CTGF) or CCN3 (NOV) but not to collagen. These activities are obliterated by mutation of the aspartate residue in the V2 peptide to alanine. The corresponding D125A mutation in the context of the N-terminal half of CCN1 (domains I and II) greatly diminished direct solid phase binding to purified integrin alphavbeta3 and abolished alphavbeta3-mediated cell adhesion activity. Likewise, soluble full-length CCN1 with the D125A mutation is defective in binding purified alphavbeta3 and impaired in alphavbeta3-mediated pro-angiogenic activities in vascular endothelial cells, including stimulation of cell migration and enhancement of DNA synthesis. In contrast, immobilized full-length CCN1-D125A mutant binds alphavbeta3 and supports alphavbeta3-mediated cell adhesion similar to wild type CCN1. These results indicate that V2 is the primary alphavbeta3 binding site in soluble CCN1, whereas additional cryptic alphavbeta3 binding site(s) in the C-terminal half of CCN1 becomes exposed when the protein is immobilized. Together, these results identify a novel and functionally important binding site for integrin alphavbeta3 and provide a new approach for dissecting alphavbeta3-specific CCN1 functions both in cultured cells and in the organism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A mutant CCN1 protein specifically mutated in the αvβ3-binding site is devoid of angiogenic activity [65].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CCN1 mutants that disrupt its α6β1-binding sites abolish α6β1-dependent activities without affecting αvβ3-mediated functions [66]. Likewise, disruption of the CCN1 αvβ3-binding site abolishes αvβ3-but not α6β1-mediated activities [65].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This inhibitory effect was observed with both CCN1 and D125A‐CCN1 mutant protein unable to bind αvβ3/αvβ5 [ 23 ] but not with DM‐CCN1 mutant protein[ 27 ] unable to bind integrin α6β1 (Figure 2C).”
From Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis (2022) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“CCN1 does not contain the canonical RGD sequence that can bind a number of integrins [54]. Instead, specific non-canonical binding sites of CCN1 for several integrins have been identified (Fig. 1) [63–66].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191
Xiong, J.-P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., & Arnaout, M. A. (2002) · Science · doi:10.1126/science.1069040 · Cited by 1,613
Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., & Smith, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000003200 · Cited by 1,356
Matricellular proteins: extracellular modulators of cell function
Bornstein, P., & Sage, E. H. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00361-7 · Cited by 965
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.
Bornstein, P. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.3.503 · Cited by 666
Pierschbacher, M. D., & Ruoslahti, E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45376-8 · Cited by 649
The CCN Family of Angiogenic Regulators: The Integrin Connection
Lau, L. F., & Lam, S. C.-T. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4456 · Cited by 648
Self-citationBork, P. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80155-n · Cited by 627
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins
Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O., & Hodivala-Dilke, K. M. (2002) · Nature Medicine · doi:10.1038/nm0102-27 · Cited by 613
Research works printed but not linked: 6
- O'Brien, 1992, Cell Growth Differ., 3, 645
- O'Brien, 1990, Mol. Cell. Biol., 10, 3569
- Yang, 1991, Cell Growth Differ., 2, 351
- Brigstock, 1999, Endocr. Rev., 20, 189
- Eliceiri, 2000, Cancer J., 6, 245
- , Grzeszkiewicz, T. M. (2002) Cyr61-induced Cellular Activities in Wound Healing: Impact of Structure on Function. Ph.D. thesis, University of Illinois at Chicago
Cited by
Jun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998
“, whereas its angiogenic activities are mediated through integrin α v β 3 (ref”
BackgroundSelf-citationAll in the CCN family: essential matricellular signaling modulators emerge from the bunker
Leask, A., & Abraham, D. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03270 · Cited by 655
Functions and mechanisms of action of CCN matricellular proteins
Chen, C.-C., & Lau, L. F. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.025 · Cited by 549
“Specific binding sites (black and hatched bars) for several integrins and HSPGs have been identified for CCN1 and CCN2 (Chen et al., 2000; Leu et al., 2003; Chen et al., 2004a; Leu et al., 2004; Gao and Brigstock, 2004; Gao and Brigstock, 2006).”
BackgroundInfluentialSelf-citationThe CCN family of proteins: structure–function relationships
Holbourn, K. P., Acharya, K. R., & Perbal, B. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.07.006 · Cited by 419
CCN1/CYR61: the very model of a modern matricellular protein
Lau, L. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0778-3 · Cited by 338
“A mutant CCN1 protein specifically mutated in the avb3-binding site is devoid of angiogenic activity [65].”
BackgroundSelf-citationBredel, M., Bredel, C., Juric, D., Harsh, G. R., Vogel, H., Recht, L. D., & Sikic, B. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1204 · Cited by 311
“The glioblastoma network included the glioma-related genes FN1 (25, 26), ITGA3 (30), ITGA5 (31), IGFBP2 (32), IGFBP3 (33), IGFBP5 (34), CD44 (18), TGFBI (20), PLAU (25), PLAUR (25), CDC2 (22), VEGF (17), PTTG1 (23), CYR61 (19, 28), and CTGF (19).”
InfluentialThe Hippo signaling pathway in development and regeneration
Zhong, Z., Jiao, Z., & Yu, F.-X. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113926 · Cited by 200
Vascular development in endometriosis
Groothuis, P. G., Nap, A. W., Winterhager, E., & Grümmer, R. (2005) · Angiogenesis · doi:10.1007/s10456-005-9005-x · Cited by 182
Cell surface receptors for CCN proteins
Lau, L. F. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0324-z · Cited by 173
Self-citationThe matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing
Jun, J.-I., Kim, K.-H., & Lau, L. F. (2015) · Nature Communications · doi:10.1038/ncomms8386 · Cited by 173
Self-citationCytotoxicity of TNFα is regulated by integrin‐mediated matrix signaling
Chen, C., Young, J. L., Monzon, R. I., Chen, N., Todorović, V., & Lau, L. F. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601596 · Cited by 143
“DM and TM were purified using anti-Flag immuno-affinity chromatography (Leu et al, 2004), whereas D125A was purified using Ni2þcolumns via its histidine tag (Chen et al, 2004).”
BackgroundMethodSelf-citationThe Evolution of Antibodies into Versatile Tumor-Targeting Agents
Lin, M. Z., Teitell, M. A., & Schiller, G. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.129.11.1 · Cited by 136
Integrin-dependent Functions of the Angiogenic Inducer NOV (CCN3)
Lin, C. G., Chen, C.-C., Leu, S.-J., Grzeszkiewicz, T. M., & Lau, L. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404903200 · Cited by 127
Self-citationO’Connor, R. S., Mills, S. T., Jones, K. A., Ho, S. N., & Pavlath, G. K. (2006) · Journal of Cell Science · doi:10.1242/jcs.03307 · Cited by 144
“These activities are thought to occur in part through the ability of Cyr61 to bind and activate cell-surface integrins (Grzeszkiewicz et al., 2001; Kireeva et al., 1998; Leu et al., 2002; Schober et al., 2002) as well as heparan sulfate proteoglycans (Chen et al., 2004).”
BackgroundThe matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts
Todorovicç, V., Chen, C.-C., Hay, N., & Lau, L. F. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504015 · Cited by 132
Self-citationRoles for CCN2 in normal physiological processes
Hall‐Glenn, F., & Lyons, K. M. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0782-7 · Cited by 129
“This motif mediates CCN2 interactions with integrins αvβ3, αvβ5 and with growth factors such as bone morphogenetic proteins (BMPs) and transforming growth factor β (TGFβ) [1,4,5,6].”
Young, N. A., Pearl, D. K., & Brocklyn, J. R. V. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0061 · Cited by 114
“to connect cellular integrins to the extracellular matrix and has been shown to stimulate cellular adhesion, migration, angiogenesis, and invasion ( 10-12 ).”
The Matricellular Protein CCN1 Is Essential for Cardiac Development
Mo, F.-E., & Lau, L. F. (2006) · Circulation Research · doi:10.1161/01.res.0000248426.35019.89 · Cited by 112
Self-citationCCN1 induces hepatic ductular reaction through integrin αvβ5–mediated activation of NF-κB
Kim, K.-H., Chen, C.-C., Alpini, G., & Lau, L. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79327 · Cited by 109
“Ccn1 D125A/D125A knock-in mice were made in a similar way by replacement of the Ccn1 genomic locus with the Ccn1-D125A allele encoding a CCN1 mutant with Asp to Ala substitution at amino acid 125, disrupting CCN1 binding to integrins α v β 5 and α v β 3 (32).”
BackgroundMethodInfluentialSelf-citationRole of CCN, a vertebrate specific gene family, in development
Katsube, K., Sakamoto, K., Tamamura, Y., & Yamaguchi, A. (2009) · Development, Growth & Differentiation · doi:10.1111/j.1440-169x.2009.01077.x · Cited by 103
“CCN1/integrin interactions enhance proangiogenesis by regulating the adhesiveness and motility of endothelial cells and smooth muscle cells (Leu et al. 2003; Chen et al. 2004).”
BackgroundCCN proteins and cancer: two to tango
Bleau, A.-M. (2005) · Frontiers in Bioscience · doi:10.2741/1594 · Cited by 97
Cyr61 Suppresses Growth of Human Endometrial Cancer Cells
Chien, W., Kumagai, T., Miller, C. W., Desmond, J. C., Frank, J. M., Said, J. W., & Koeffler, H. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410254200 · Cited by 96
Lin, M.-T., Zuon, C.-Y., Chang, C.-C., Chen, S.-T., Chen, C.-P., Lin, B.-R., Wang, M.-Y., Jeng, Y.-M., Chang, K.-J., Lee, P.-H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2639 · Cited by 90
The matricellular protein CCN1 in tissue injury repair
Kim, K., Won, J. H., Cheng, N., & Lau, L. F. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0450-x · Cited by 91
Self-citationHove, I. V., Hu, T., Beets, K., Bergen, T. V., Etienne, I., Stitt, A. W., Vermassen, E., & Feyen, J. H. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100966 · Cited by 81
Yan, L., Lee, S., Lazzaro, D. R., Aranda, J., Grant, M. B., & Chaqour, B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646950 · Cited by 73
“However, these biological activities are context-specific and depend on the interaction of the CCN1 protein with other growth factors and/or receptors (53, 54, 55).”
BackgroundTuru, M. M., Slevin, M., Matou, S., West, D., Rodríguez, C., Luque, A., Grau-Olivares, M., Badimon, L., Martinez-Gonzalez, J., & Krupinski, J. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-47 · Cited by 75
“CRP purity was checked by SDS-PAGE followed by Coomassie blue staining where CRP was identified as a single band [57].”
Gellhaus, A. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal044 · Cited by 72
“CYR61 and NOV have been shown to promote proangiogenic activities in endothelial cells in vivo through integrin receptors and are highly expressed in vascular structures during embryogenesis (Babic et al., 1998; Ellis et al., 2000, 2003; Leu et al., 2002; Lin et al., 2003; Chen et al., 2004 ).”
BackgroundTargeted Mutagenesis of the Angiogenic Protein CCN1 (CYR61)
Leu, S.-J., Chen, N., Chen, C.-C., Todorović, V., Bai, T., Juric, V., Liu, Y., Yan, G., Lam, S. C.-T., & Lau, L. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407850200 · Cited by 72
Self-citationZhou, D., Herrick, D. J., Rosenbloom, J., & Chaqour, B. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01093.2004 · Cited by 70
Juric, V., Chen, C.-C., & Lau, L. F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00064-09 · Cited by 70
Self-citationCCN1: a novel inflammation-regulated biphasic immune cell migration modulator
Löbel, M., Bauer, S., Meisel, C., Eisenreich, A., Kudernatsch, R., Tank, J., Rauch, U., Kühl, U., Schultheiß, H., Volk, H., et al. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0981-x · Cited by 75
Franzen, C. A., Chen, C.-C., Todorović, V., Juric, V., Monzon, R. I., & Lau, L. F. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0017 · Cited by 66
“TM and D125A, which contain missense mutations targeting specific receptor binding sites and are unable to bind α6β1HSPG or αvβ3, respectively (22, 23).”
BackgroundSelf-citationChien, W., Yin, D., Gui, D., Mori, A., Frank, J. M., Said, J., Kusuanco, D., Marchevsky, A., McKenna, R., & Koeffler, H. P. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0029 · Cited by 64
“The CCN proteins are multifunctional and are involved in cell adhesion, angiogenesis, cell differentiation, and tumorigenesis (4-8).”
BackgroundThe matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6
Choi, J. S., Kim, K.-H., & Lau, L. F. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.19 · Cited by 62
Self-citationThe CCN Family Proteins: Modulators of Bone Development and Novel Targets in Bone-Associated Tumors
Chen, P., Cheng, H., Yang, S., Lin, C., & Tang, C. (2014) · BioMed Research International · doi:10.1155/2014/437096 · Cited by 67
Kaasbøll, O. J., Gadicherla, A. K., Wang, J., Monsen, V. T., Hagelin, E. M. V., Dong, M., & Attramadal, H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004559 · Cited by 61
CCN1 interacts with integrins to regulate intestinal stem cell proliferation and differentiation
Won, J. H., Choi, J. S., & Jun, J.-I. (2022) · Nature Communications · doi:10.1038/s41467-022-30851-1 · Cited by 65
CCN1 Knockdown Suppresses Neointimal Hyperplasia in a Rat Artery Balloon Injury Model
Matsumae, H., Yoshida, Y., Ono, K., Togi, K., Inoue, K., Furukawa, Y., Nakashima, Y., Kojima, Y., Nobuyoshi, M., Kita, T., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.162362 · Cited by 59
Conjunction junction, what’s the function? CCN proteins as targets in fibrosis and cancers
Leask, A. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00028.2020 · Cited by 65
Crockett, J. C., Schütze, N., Tosh, D., Jatzke, S., Duthie, A., Jakob, F., & Rogers, M. J. (2007) · Endocrinology · doi:10.1210/en.2007-0473 · Cited by 57
CCN1 is an opsonin for bacterial clearance and a direct activator of Toll-like receptor signaling
Jun, J.-I., & Lau, L. F. (2020) · Nature Communications · doi:10.1038/s41467-020-15075-5 · Cited by 58
Self-citationRother, M., Krohn, S., Kania, G., Vanhoutte, D., Eisenreich, A., Wang, X., Westermann, D., Savvatis, K., Dannemann, N., Skurk, C., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.945261 · Cited by 53
Wolf, N., Yang, W., Dunk, C. E., Gashaw, I., Lye, S. J., Ring, T., Schmidt, M., Winterhager, E., & Gellhaus, A. (2010) · Endocrinology · doi:10.1210/en.2009-1195 · Cited by 52
YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis
Wu, Z., Su, J., Li, F.-L., Chen, T., Mayner, J., Engler, A. J., Ma, S., Li, Q., & Guan, K. (2023) · Nature Communications · doi:10.1038/s41467-023-41585-z · Cited by 64
Chen, C.-C., Kim, K.-H., & Lau, L. F. (2015) · Oncogene · doi:10.1038/onc.2015.190 · Cited by 52
“This activity was abrogated in the DM but not the D125A mutant, and blocked by pre-incubation with a function-blocking mAb against integrin α6 (GoH3)(Fig.”
BackgroundSelf-citationGellan Gum Hydrogels with Enzyme‐Sensitive Biodegradation and Endothelial Cell Biorecognition Sites
da Silva, L. P., Jha, A. K., Correlo, V. M., Marques, A. P., Reis, R. L., & Healy, K. E. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700686 · Cited by 55
Lin, B.-R., Chang, C.-C., Chen, L.-R., Wu, M.-H., Wang, M.-Y., Kuo, I.-H., Chu, C.-Y., Chang, K.-J., Lee, P.-H., Chen, W.-J., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0289 · Cited by 51
“Actually, most of the Cyr61-promoted effects, including cell adhesion, migration, and differentiation, are mediated via its direct binding with the integrin receptor avh3 (28, 40, 54, 55), which has been implicated in the pathophysiology of malignant tumors.”
BackgroundThe role of the CCN family of proteins in female reproduction
Winterhager, E., & Gellhaus, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1556-9 · Cited by 54
Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells
Eisenreich, A., Zakrzewicz, A., Huber, K., THIERBACH, H., Pepke, W., Goldin-Lang, P., Schultheiß, H., Pries, A. R., & Rauch, U. (2013) · Oncology Reports · doi:10.3892/or.2013.2413 · Cited by 48
Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine‐rich protein 61
Walsh, C. T., Radeff‐Huang, J., Matteo, R., Hsiao, A., Subramaniam, S., Stupack, D., & Brown, J. H. (2008) · The FASEB Journal · doi:10.1096/fj.08-113266 · Cited by 47
Saigusa, R., Asano, Y., Taniguchi, T., Yamashita, T., Takahashi, T., Ichimura, Y., Toyama, T., Tamaki, Z., Tada, Y., Sugaya, M., et al. (2014) · Experimental Dermatology · doi:10.1111/exd.12602 · Cited by 46
You, J.-J., Yang, C., Yang, C., & Chen, M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.026 · Cited by 47
Global analysis of differential luminal epithelial gene expression at mouse implantation sites
Chen, Y., Ni, H., Ma, X., Hu, S., Luan, L., Ren, G., Zhao, Y., Li, S., Diao, H., Xu, X. Q., et al. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02009 · Cited by 51
“Cyr61 and Ctgf supported the attachment of endothelial cells through integrin avb3 (Kireeva et al. 1998) and cell surface heparan sulfate proteoglycans (Chen et al. 2000, 2004).”
BackgroundSCO-spondin, a giant matricellular protein that regulates cerebrospinal fluid activity
Sepúlveda, V., Maurelia, F., González, M., Aguayo, J., & Caprile, T. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00277-w · Cited by 48
Uneda, A., Kurozumi, K., Fujimura, A., Fujii, K., Ishida, J., Shimazu, Y., Otani, Y., Tomita, Y., Hattori, Y., Matsumoto, Y., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01124-7 · Cited by 52
Cyr61, a Matricellular Protein, Is Needed for Dendritic Arborization of Hippocampal Neurons
Malik, A. R., Urbanska, M., Gozdz, A., Swiech, L. J., Nagalski, A., Perycz, M., Blazejczyk, M., & Jaworski, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.411629 · Cited by 45
Kerr, B. A., & Byzova, T. V. (2010) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a001211.01 · Cited by 42
B, J. R. V. B., & Griffioen, A. W. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.06.001 · Cited by 42
G Protein-Coupled Receptors Go Extracellular: RhoA Integrates the Integrins
Walsh, C. T., Stupack, D., & Brown, J. H. (2008) · Molecular Interventions · doi:10.1124/mi.8.4.8 · Cited by 40
Liu, B., Zhang, J., Zhang, X., Wu, G., & Li, M.-X. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.05.029 · Cited by 38
“CYR61 acts as an inducer of angiogenesis essential for successful vascular development by binding to integrin α5β3 via its C-terminal [16].”
BackgroundCyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL -mutant renal carcinoma cells
Chintalapudi, M. R., Markiewicz, M., Kose, N., Dammai, V., Champion, K. J., Hoda, R. S., Trojanowska, M., & Hsu, T. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn019 · Cited by 37
Whitson, R. J., Lucia, M. S., & Lambert, J. R. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24484 · Cited by 37
“CCN proteins carry out pro-angiogenic functions in endothelial cells through their VWC domains [Babic et al., 1999; Lau and Lam, 1999; Shimo et al., 1999; Brigstock, 2002; Lin et al., 2003; Chen et al., 2004].”
BackgroundResultInfluentialProteolysis of CCN1 by Plasmin: Functional Implications
Pendurthi, U. R., Tran, T. T., Post, M., & Rao, L. V. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0982 · Cited by 38
“Recent studies identified a novel 20-residue sequence in the VWC domain of CCN1 (residues 116-135) as a functional binding site for integrin avh3 ( 44 ).”
BackgroundKassis, J. N., Virador, V. M., Guancial, E. A., Kimm, D., Ho, A. S., Mishra, M., Chuang, E. Y., Cook, J., Gius, D., & Kohn, E. C. (2009) · The Journal of Pathology · doi:10.1002/path.2557 · Cited by 34
Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer Development
D'Antonio, K. B., Toubaji, A., Albadine, R., Mondul, A. M., Platz, E. A., Netto, G. J., & Getzenberg, R. H. (2010) · Journal of Urology · doi:10.1016/j.juro.2009.12.006 · Cited by 34
Yan, L., & Chaqour, B. (2013) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-013-0206-6 · Cited by 37
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis
Mooring, M., Yeung, G. A., Luukkonen, P., Liu, S., Akbar, M. W., Zhang, G. J., Balogun, O., Yu, X., Mo, R., Nejak-Bowen, K., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade3157 · Cited by 33
“Although deletion of CYR61 has beneficial effects on fibrosis, inflammation, and metabolic signaling, its known roles in ductular reaction (22), angiogenesis (57, 58), and cellular senescence (59, 60) suggest that there may be deleterious long-term aspects of repair and regeneration that should be considered.”
BackgroundCYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process
Habel, N., Stefanovska, B., Carène, D., Patiño‐García, A., Lecanda, F., & Fromigué, O. (2019) · BMC Cancer · doi:10.1186/s12885-019-5282-4 · Cited by 37
Thaler, K. J., Mack, J. A., Berho, M. E., Grotendorst, G. R., Wexner, S. D., & Abramson, S. (2005) · European Surgical Research · doi:10.1159/000087869 · Cited by 29
“While a spatial relationship between CTGF expression and new vessel formation was observed at all postoperative time-points only some days correlated in a temporal pattern. This suggests the involvement of additional factors or feedback mechanism in regulating angiogenesis in adhesion formation and warrants future inv…”
BackgroundJohnson, S., Stewart, P., Bam, R., Qu, P., Barlogie, B., van Rhee, F., Shaughnessy, J. D., Epstein, J., & Yaccoby, S. (2014) · Blood · doi:10.1182/blood-2014-02-555813 · Cited by 29
Eisenreich, A., Boltzen, U., Malz, R., Schultheiß, H., & Rauch, U. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-0783 · Cited by 28
Functional Vascular Tissue Engineering Inspired by Matricellular Proteins
Ramaswamy, A. K., Vorp, D. A., & Weinbaum, J. S. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00074 · Cited by 27
Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors
Habel, N., Vilalta, M., Bawa, O., Opolon, P., Blanco, J., & Fromigué, O. (2014) · Oncogene · doi:10.1038/onc.2014.232 · Cited by 29
Kim, K., Cheng, N., & Lau, L. F. (2022) · Hepatology Communications · doi:10.1002/hep4.2057 · Cited by 26
Self-citationThe matrix protein CCN1/CYR61 is required for αVβ5‐mediated cancer cell migration
Jandová, J., Beyer, T. E., Meuillet, E. J., & Watts, G. S. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2853 · Cited by 28
Maeta, N., Osaki, M., Shomori, K., Inaba, A., Kidani, K., Ikeguchi, M., & Ito, H. (2007) · Oncology · doi:10.1159/000121000 · Cited by 28
“CYR61, as well as the other CCN members, is a secretory protein and associates with the extracellular matrix (ECM) and several integrins at the cell surface [”
BackgroundYin, J.-H., Shi, W.-D., Zhu, X.-Y., Chen, Z., & Liu, L.-M. (2011) · Integrative Cancer Therapies · doi:10.1177/1534735411400315 · Cited by 26
An overview of CCN4 (WISP1) role in human diseases
Singh, K., & Oladipupo, S. S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05364-8 · Cited by 30
“…of multi-ligand receptors and proteins, ranging from ECM proteins (such as fibronectin [10, 11], vitronectin [12], perlecan [13], integrins [14–16], growth factors (such as fibroblast growth factors (FGFs) [17–19], vascular endothelial growth factor (VEGF) [20], bone morphogenetic protein…”
BackgroundDecreased Expression of Cyr61 Is Associated with Prostate Cancer Recurrence after Surgical Treatment
D'Antonio, K. B., Schultz, L., Albadine, R., Mondul, A. M., Platz, E. A., Netto, G. J., & Getzenberg, R. H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1200 · Cited by 26
Wang, L., Lee, J.-F., Lin, C., & Lee, M.-J. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0389-8 · Cited by 25
“, -actinin, vinculin, talin) with integrin v 3 (Brooks et al. 1994a, b; Chen et al. 2004; Gao and Brigstock 2004; Tsou and Isik 2001).”
BackgroundDifferential Effects of MicroRNAs on Glioblastoma Growth and Migration
Jeansonne, D. P., Pacifici, M., Lassak, A., Reiss, K., Russo, G. M., Zabaleta, J., & Peruzzi, F. (2013) · Genes · doi:10.3390/genes4010046 · Cited by 21
Schütze, N., Jüngel, E., Blaheta, R. A., Naggi, A., Torri, G., Schmitz, P., Gerber, U., & Bendas, G. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0158 · Cited by 20
Structural insights into regulation of CCN protein activities and functions
Monsen, V. T., & Attramadal, H. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00768-5 · Cited by 24
“A D125A point mutation within this region abrogated binding of CCN1 to αvβ3/αvβ5 integrin (Chen et al. 2004; Leu et al. 2004) and mice expressing the CCN1 D125/D125 mutant displayed hepatic necrosis after bile duct”
BackgroundWang, L., Yao, L., Duan, H., Yang, F., Lin, M., Zhang, R., He, Z., Ahn, J., Fan, Y., Qin, L., et al. (2021) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4423 · Cited by 19
Menéndez, J. A., Vellón, L., Espinoza, I. C., & Lupu, R. (2016) · Oncoscience · doi:10.18632/oncoscience.314 · Cited by 20
Hwang, S., Lee, H.-J., Kim, G., Won, K., Park, Y. S., & Jo, I. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.005 · Cited by 19
Espinoza, I. C., Menéndez, J. A., Chandra Mohan, K. V. P., & Lupu, R. (2013) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-013-0214-6 · Cited by 20
“…matrix (Yang and Lau 1991), belongs to the Cysteine rich 61/Connective tissue growth factor/Nephroblastoma overexpressed (CCN) gene-family of angiogenic and growth regulators (Grote et al. 2007; Chen et al. 2001, 2004; Ivkovic et al. 2003; Hashimoto et al. 2002; Dean et al. 2007; Brigstock 2002).”
BackgroundCCN1: a novel target for pancreatic cancer
Leask, A. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0127-1 · Cited by 16
“CCN1 promotes migration, adhesion, angiogenesis and tumor growth through an integrin-dependent mechanism (Babic et al. 1998; Chen et al. 2004 ).”
BackgroundTherapeutic potential of cysteine-rich protein 61 in rheumatoid arthritis
Xu, T., He, Y., Wang, M., Yao, H.-W., Ni, M.-M., Zhang, L., Meng, X., Huang, C., Ge, Y., & Li, J. (2016) · Gene · doi:10.1016/j.gene.2016.07.053 · Cited by 17
Roberts, D. D., & Lau, L. F. (2010) · Springer eBooks · doi:10.1007/978-3-642-16555-9_11 · Cited by 20
Self-citationPyrko, P., Wang, W., Markland, F. S., Swenson, S. D., Schmitmeier, S., Schönthal, A. H., & Chen, T. C. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.3.0526 · Cited by 15
The matricellular protein CCN5 regulates podosome function via interaction with integrin αvβ3
Myers, R. B., Lan, W., & Castellot, J. J. (2014) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-013-0218-2 · Cited by 16
“Like all CCN proteins, CCN5 lacks the prototypical integrin recognition sequence Arg-Gly-Asp (RGD), but it does contain a stretch of amino acids that is very similar to the integrin αvβ3 binding site in CCN1 (Chen et al. 2004) (Fig.”
BackgroundInfluentialAstrocyte CCN1 stabilizes neural circuits in the adult brain
Sancho, L., Boisvert, M., Eddy, T., Burgado, J., Contreras, M., Labarta-Bajo, L., Wang, E., Tatsumi, L., & Allen, N. J. (2025) · Nature · doi:10.1038/s41586-025-09770-w · Cited by 19
McNeill, B., Vulesevic, B., Ostojic, A., Ruel, M., & Suuronen, E. J. (2014) · The FASEB Journal · doi:10.1096/fj.14-261586 · Cited by 14
Leu, S.-J. J., Sung, J.-S., Huang, M.-L., Chen, M., & Tsai, T.-W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.045 · Cited by 14
Self-citationCysteine-rich matricellular protein improves callus regenerate in a rabbit trauma model
Frey, S. P., Hoelscher‐Doht, S., Eden, L., Dannigkeit, S., Schütze, N., Meffert, R. H., & Jansen, H. (2012) · International Orthopaedics · doi:10.1007/s00264-012-1659-6 · Cited by 14
“In particular, proangiogenic acitivities of CYR61 are mediated through integrins αvβ3 and α6β1 in endothelial cells [18, 19].”
BackgroundTiwari, K., Saravanan, A., Anil, A., Tiwari, V. K., Shamim, M. A., Singh, S., Dwivedi, P., Deora, S., & Varthya, S. B. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x332671241121063641 · Cited by 13
CYR61 delivery promotes angiogenesis during bone fracture repair
Lang, A., Eastburn, E. A., Younesi, M., Nijsure, M. P., Siciliano, C., Haran, A. P., Panebianco, C. J., Seidl, E., Tang, R., Alsberg, E., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00398-y · Cited by 15
CYR61 as a Potential Biomarker and Target in Cancer Prognosis and Therapies
Schenker, A. J., & Ortiz-Hernández, G. L. (2025) · Cells · doi:10.3390/cells14110761 · Cited by 13
“While there are several α v β 3 binding sites, Asp-125 in the 20-residue sequence of the vWC domain of V2 is particularly critical for integrin interactions [57].”
Metadata
- Authors
- Chen, N., Leu, S.-J., Todorović, V., Lam, S. C.-T., & Lau, L. F.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Lau, Lester F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 279
- Issue
- 42
- Pages
- 44166-44176
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035497705
- Cited by
- 132
- References
- 60
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 6 · 2015: 6 · 2014: 7 · 2013: 10 · 2012: 3
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5927 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca080080-05)
- National Heart, Lung, and Blood Institute (HL41793)
- National Cancer Institute (CA-80080, R01CA046565, CA-46565)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- CYR61, integrin αvβ3, integrin binding site, matricellular proteins, angiogenesis, endothelial cell adhesion, endothelial cell migration, connective tissue growth factor, CCN3, aspartic acid residues, protein immobilization
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Cell Adhesion, Cell Movement, Cells, Cultured, Endothelium, Vascular, Humans, Kinetics, Molecular Sequence Data, Recombinant Proteins, Umbilical Veins, Mutagenesis, Site-Directed, Immediate-Early Proteins, DNA Primers, Neovascularization, Physiologic, Protein Isoforms, Intercellular Signaling Peptides and Proteins, Integrin alphaVbeta3, Mice, Cysteine-Rich Protein 61
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.